Putting the award page together from the records…
Putting the award page together from the records…
LEUKINE 250MCG VIL INJ (5PKG)
Up for re-bid: ends 2027-03-29. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
8 actions since 2023-09-26. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-10 | P00007 | Option exercised | $34.20M | EXERCISE OPTIONAL ORDERING PERIOD 2 FOR LEUKINE 250MCG VIAL INJECTABLES |
| 2026-03-26 | P00006 | Option exercised | $15.80M | LEUKINE 250MCG QTY 14,635 AT THE UNIT PRICE OF $1,079.60 |
| 2025-09-08 | P00005 | Administrative change | $0 | LEUKINE 250MCG VIL INJ (5PKG) |
| 2025-05-15 | P00004 | Option exercised | $20.00M | LEUKINE 250MCG VIL INJ (5PKG) |
| 2024-11-06 | P00003 | Option exercised | $19.11M | LEUKINE 250MCG VIL INJ (5PKG) |
| 2024-10-02 | P00002 | Change order | $0 | LEUKINE 250MCG VIL INJ (5PKG) |
| 2024-08-05 | P00001 | Option exercised | $22.20M | LEUKINE 250MCG VIL INJ (5PKG) |
| 2023-09-26 | 0 | $22.20M | LEUKINE 250MCG VIL INJ (5PKG) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗